ℹ️
🇬🇧
Search
Search for publications relevant for "Germinal Center"
Germinal Center
Publication
Class
Person
Publication
Programmes
Export current view
publication
The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study
2011 |
First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
Expression pattern of adaptor protein PAG: Correlation between secondary lymphatic follicle and histogenetically related malignant lymphomas
2005 |
Third Faculty of Medicine
publication
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
2019 |
Faculty of Medicine in Hradec Králové
publication
Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools
2021 |
Second Faculty of Medicine
publication
Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells
2024 |
Second Faculty of Medicine
publication
Primary DLBCL lymphoma in sacral bone - case report
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Follicular Helper T Cells in DiGeorge Syndrome
2018 |
Second Faculty of Medicine
publication
Influence of Radiofrequency Surgery on Architecture of the Palatine Tonsils
2014 |
First Faculty of Medicine
publication
Exhausted phenotype of follicular CD8 T cells in CVID
2020 |
Second Faculty of Medicine
publication
Lymphoepithelial Cyst of the Pancreas: A Case Report
2018 |
Third Faculty of Medicine
publication
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL
2017 |
First Faculty of Medicine
publication
Dimethyl fumarate induces ferroptosis and impairs NF-kappa B/STAT3 signaling in DLBCL
2021 |
First Faculty of Medicine
publication
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma
2020 |
First Faculty of Medicine
publication
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis
2023 |
First Faculty of Medicine
publication
mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Quantitative histology by multicolor slide-based cytometry
2004 |
Third Faculty of Medicine
publication
Primary cutaneous marginal zone lymphoma in children: A Report of 3 Cases and Review of the Literature
2014 |
Faculty of Medicine in Pilsen
publication
Spectrum of lesions derived from branchial arches occurring in the thyroid: from solid cell nests to tumors
2017 |
First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study
2020 |
First Faculty of Medicine
publication
Immunotoxic effects of carbon tetrachloride - the effect an morphology and function of the immune system in mice
1996 |
Third Faculty of Medicine
publication
Can Cutaneous Low-Grade B-cell Lymphoma Transform Into Primary Cutaneous Diffuse Large B-cell Lymphoma? An Immunohistochemical Study of 82 cases
2014 |
Faculty of Medicine in Pilsen
publication
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
2017 |
Publication without faculty affiliation
publication
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2017 |
First Faculty of Medicine
publication
EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System
2019 |
Second Faculty of Medicine
publication
A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
2020 |
First Faculty of Medicine
publication
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study
2022 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové